| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), BCRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.34M | $13.00M | - | |
| CFO | 268.7K | - | - | |
| Other | 205.2K | - | - | |
| Dir | 109.6K | $1.06M | - | |
| Dir | 80.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2019 | Aselage Steve80 | Director | Buy | 15,000 | $1.45 | $21,750.00 | +224.8% | |
| May 22, 2019 | Aselage Steve80 | Director | Buy | 3,000 | $3.57 | $10,710.00 | +150.0% | |
| May 17, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 9,750 | $7.65 | $74,595.00 | -7.2% | |
| May 15, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 11,750 | $7.81 | $91,710.00 | -8.3% | |
| May 13, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 19,500 | $7.70 | $150,052.50 | -12.8% | |
| May 6, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 16,750 | $7.54 | $126,325.00 | -11.2% | |
| Apr 4, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 7,500 | $8.81 | $66,075.00 | -5.4% | |
| Mar 12, 2019 | Aselage Steve80 | Director | Buy | 2,000 | $8.30 | $16,600.00 | New | |
| Jan 28, 2019 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 5,000 | $9.85 | $49,250.00 | -3.7% | |
| Jan 28, 2019 | Powell Lynne | Senior VP - CCO | Sale+OE | 12,000 | $9.75 | $116,940.00 | -100% |